Dr. Reddy's Laboratories Ltd. (DRREDDY): Dr. Reddy's Laboratories Share Price rises 2.18% as stock gains today

Published: 28 September 2026 at 1:22:31 PM IST

Dr. Reddy's Laboratories Share Price rose to Rs 1,229 today, up 2.18% from the previous close of Rs 1,202.80, with the company valued at Rs 1,00,395.34 crore in market capitalisation. The move places Dr. Reddy's Laboratories Ltd. in focus in today's stock news, while the supplied data confirms the price event but does not establish a company-specific catalyst. For readers tracking Dr. Reddy's Laboratories Share Price Today, the key facts are straightforward: the stock opened at Rs 1,207, touched a high of Rs 1,229.80 and a low of Rs 1,204.15, and ended the session near its high. Univest is covering the event as part of its live market update so investors can place the move alongside valuation, sector and peer context rather than treat it in isolation.

In today's Indian stock market, this is a clear price rise rather than a broad rerating claim. The day’s turnover was Rs 18.62 crore, which is a factual traded-value metric and should be read as context, not as proof of participation or conviction. For those searching Dr. Reddy's Laboratories Stock News, the important question is not only what changed in price, but how today's movement sits against company fundamentals, healthcare sector benchmarks and listed peers.

Dr. Reddy's Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,229
Previous Close	Rs 1,202.8
Today's Move	Rs 26.2 (+2.18%)
Open	Rs 1,207
High	Rs 1,229.8
Low	Rs 1,204.15
Turnover	Rs 18.62 crore
Market Capitalisation	Rs 1,00,395.34 crore
Market Cap Category	Large Cap

Dr. Reddy's Laboratories Ltd. (DRREDDY) rose to Rs 1,229 from the previous close of Rs 1,202.8, a move of Rs 26.2 or 2.18%. The stock opened at Rs 1,207, reached a high of Rs 1,229.8, recorded a low of Rs 1,204.15.

Dr. Reddy's Laboratories Share Price Today shows a rise of Rs 26.20 or 2.18% from Rs 1,202.80 to Rs 1,229. The stock opened at Rs 1,207, moved within a day range of Rs 1,204.15 to Rs 1,229.80, and closed just below the session high. That makes today’s move a clean same-day share price gain, with the supplied data confirming the event but not assigning a reason. Dr. Reddy's Laboratories Stock Performance can therefore be read as a factual upward move in price, not as a claimed breakout or event-led reaction. On a share price basis, the stock is also being watched as one of the more notable movers within the healthcare universe today, even though the data itself does not establish why the market valued it higher intraday.

Dr. Reddy's Laboratories Ltd. (DRREDDY) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,00,395.34 crore
P/E Ratio	31.16x
P/B Ratio	2.63x
ROE	11.69%
ROCE	13.75%
EPS	Rs 38.6
Book Value Per Share	Rs 457.39
Dividend Yield	0.67%

Dr. Reddy's Laboratories Ltd. (DRREDDY) fundamental metrics show P/E 31.16x, P/B 2.63x, ROE 11.69%, ROCE 13.75%. These figures provide context only and are not a buy or sell signal.

Dr. Reddy's Laboratories Ltd. has a market capitalisation of Rs 100395.34 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.16x, P/B at 2.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.69% and ROCE of 13.75%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 38.6, book value per share of Rs 457.39, dividend yield of 0.67%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.16x
Benchmark Median P/E	32.87x
Benchmark Average P/E	49.63x
Benchmark P/E Range	3.46x to 735.85x
Company P/B Ratio	2.63x
Benchmark Median P/B	2.85x
Company ROE	11.69%
Benchmark Median ROE	11.48%
Company ROCE	13.75%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 1,00,395.34 crore
Benchmark Median Market Cap	Rs 732.57 crore

Dr. Reddy's Laboratories Ltd. (DRREDDY) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 31.16x, which is below the benchmark median of 32.87x, a difference of -5.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROE of 11.69%, which is above the benchmark median of 11.48%, a difference of +1.83%. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROCE of 13.75%, which is above the benchmark median of 13.17%, a difference of +4.4%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	87.22	14.44	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	86.94	21.13	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.57	4.45	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.49	3.21	11.83	16

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 31.16x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.75% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a market capitalisation of Rs 1,00,395.34 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Dr. Reddy's Laboratories

• Dr. Reddy's Laboratories Share Price rose 2.18% today to Rs 1,229 from Rs 1,202.80.
• The stock opened at Rs 1,207 and closed near the day high of Rs 1,229.80.
• Market capitalisation stands at Rs 1,00,395.34 crore, giving size context to the move.
• P/E of 31.16 and P/B of 2.63 place the stock below the industry median on both measures.
• ROE of 11.69 and ROCE of 13.75 are both above the same-industry median, while EPS is Rs 38.60 and book value is Rs 457.39.

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for operating in medicines and related pharmaceutical products, though this note stays limited to the supplied market and financial data. For readers following Dr. Reddy's Laboratories Stock News, the company’s identity is anchored in a large market capitalisation, a measured valuation profile and return ratios that are close to industry norms. That combination makes the stock relevant in both market updates and fundamental analysis discussions.

In practical terms, Dr. Reddy's Laboratories Share Price Today reflects how the market is currently valuing that business at Rs 1,229 per share. The supplied financials show EPS of Rs 38.60, book value of Rs 457.39 and a dividend yield of 0.67. Those figures help investors understand the share price in relation to earnings, accounting value and historical payout context. Univest tracks such company-level data to help readers compare price action with fundamentals rather than isolate the move from the broader business picture.

Track Dr. Reddy's Laboratories Share Price on Univest

Use Dr. Reddy's Laboratories Ltd. (DRREDDY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Dr. Reddy's Laboratories Share Price on Univest for live share price updates, market cap, valuation ratios, company financials, shareholding pattern, sector context and key market insights. Univest also presents the stock alongside industry and peer comparisons so users can review Dr. Reddy's Laboratories Share Price Today in one place.

Frequently Asked Questions

Why did Dr. Reddy's Laboratories Share Price rise today?

Ans. The supplied data confirms that Dr. Reddy's Laboratories Share Price rose 2.18% today to Rs 1,229, but it does not establish a company-specific catalyst. The move is best read through price action, valuation and sector context.

What is Dr. Reddy's Laboratories Share Price today?

Ans. Dr. Reddy's Laboratories Share Price today is Rs 1,229. It is up Rs 26.20 from the previous close of Rs 1,202.80, with the stock trading between Rs 1,204.15 and Rs 1,229.80 during the session.

How much did Dr. Reddy's Laboratories stock gain today?

Ans. Dr. Reddy's Laboratories stock gained Rs 26.20, or 2.18%, in today's session. The move came on a turnover of Rs 18.62 crore and left the share price near the day's high.

What is Dr. Reddy's Laboratories market capitalisation?

Ans. Dr. Reddy's Laboratories has a market capitalisation of Rs 1,00,395.34 crore. That places it well above the same-industry median in the supplied benchmark set and gives the stock significant scale in healthcare.

Is Dr. Reddy's Laboratories expensive compared with peers?

Ans. The stock's P/E of 31.16 is below the same-industry median of 32.87 and much lower than several peers such as Divi's Laboratories and Torrent Pharmaceuticals. That makes it look more moderate than the higher-multiple names.

What do Dr. Reddy's Laboratories ROE and ROCE show?

Ans. ROE is 11.69 and ROCE is 13.75. Both are above the same-industry medians of 11.48 and 13.17, which suggests the stock is generating returns that are at least slightly better than the benchmark set.

What is the EPS and book value of Dr. Reddy's Laboratories?

Ans. Dr. Reddy's Laboratories reports EPS of Rs 38.60 and book value of Rs 457.39. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

Does Dr. Reddy's Laboratories pay a dividend?

Ans. The supplied dividend yield is 0.67. That is a historical or current yield measure, not a promise of future payout, and it adds income context to the share price and valuation discussion.